What Pediatricians, Pediatric Researchers and Scientists Need to Know About US National Child Health Policy in 2020
The 2020 Pediatric Academic Societies’ Meeting would have been the first major national conference during a consequential federal election year, but was cancelled because of the pandemic. Many pediatric scientists, researchers and clinicians are unfamiliar with the impact of pending legislation, administrative rules and executive orders on all forms of scientific research, social determinants of health and the clinical practice of modern pediatrics. These talks, originally slated for the 2020 Pediatric Academic Societies' Meeting, will update attendees on major child-health related policy issues from the standpoint of academic pediatrics. Non-partisan experts will deliver issues-focused updates in areas of their research/expertise.
Pediatric scientists, researchers and clinicians
Upon completion of this activity you will be able to:
- Identify the scope of Medicaid as an insurance vehicle for children
- Determine potential causes for changes in the rates of pediatric health insurance coverage
- Discuss racial/ethnic inequities in child health
- Describe impact of COVID-19 on children of color
- Identify policy issues for children of color
- Describe the effects of gun violence on child health
- Illustrate the evidence behind important legislative polices to decrease gun deaths and injuries
- Discuss strategies to decrease gun violence in 2020
- Delineate air and water contaminants, health risks, and related policies
- Critique current trends child health, including insurance coverage for children
- Discuss what Congress is doing to address child health issues
- Summarize the history, epidemiology, structural causes and impacts of child poverty in the United States
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this continuing education (CE) activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity all conflicts of interest have been resolved and detailed disclosures are listed below.
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.175 continuing education units (CEUs) or 1.75 hours.
- 1.75 AMA PRA Category 1 Credit™
- 1.75 University of Wisconsin–Madison Continuing Education Hours
Free, current version of Chrome, Firefox, Safari, or Microsoft Edge with audio and video capabilities. Some older browsers and Microsoft Explorer could produce error messages or not display the content correctly.
Enable pop ups for ce.icep.wisc.edu through your browser settings.